Impact of oral isotretinoin on the inflammatory markers: can lymphocyte/HDL-C and platelet/HDL-C ratios be new indicators of inflammation in acne vulgaris patients?
dc.authorid | zorlu, ozge/0000-0001-5555-130X | |
dc.authorid | Albayrak, Hulya/0000-0002-2022-578X | |
dc.contributor.author | Zorlu, Ozge | |
dc.contributor.author | Albayrak, Hulya | |
dc.contributor.author | Aytekin, Sema | |
dc.date.accessioned | 2025-04-06T12:23:51Z | |
dc.date.available | 2025-04-06T12:23:51Z | |
dc.date.issued | 2024 | |
dc.department | Tekirdağ Namık Kemal Üniversitesi | |
dc.description.abstract | Introduction: The effect of isotretinoin on inflammatory markers has been reported with conflicting results. No studies have been reported on the relationship between isotretinoin and lymphocyte/high-density lipoprotein cholesterol [HDL-C] ratio (LHR), neutrophil/HDL-C ratio (NHR), or platelet/HDL-C ratio (PHR) in acne patients. Objectives: We aimed to investigate how isotretinoin affects the inflammatory markers, including LHR, NHR, and PHR, in acne vulgaris patients. Methods: A total of 361 patients with moderate-to-severe acne vulgaris who received systemic isotretinoin for at least six months were included. Complete blood count and biochemical analyses, including monocyte/HDL-C ratio (MHR), NHR, LHR, PHR, neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), the aggregate index of systemic inflammation (AISI), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), obtained at the treatment onset and the end of the first, third, and sixth months of treatment were investigated. Results: There was no significant difference in MHR and NHR levels between repeated measures. A significant increasing trend was seen in LHR and PHR (P = 0.001 and P = 0.011, respectively). HDL-C levels gradually and significantly declined during the six months (P < 0.001). Serum NLR, derived NLR, SII, SIRI, MLR, and AISI showed a significant decrease in line with clinical improvement in acne during the six months of therapy (P < 0.05). Conclusions: Declining levels of NLR, MLR, SII, SIRI, and AISI may indicate the anti-inflammatory effects of isotretinoin on the pilosebaceous unit, whereas increasing levels of LHR and PHR may show systemic inflammatory activity of isotretinoin. | |
dc.identifier.doi | 10.1080/15569527.2024.2423257 | |
dc.identifier.endpage | 389 | |
dc.identifier.issn | 1556-9527 | |
dc.identifier.issn | 1556-9535 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 39498542 | |
dc.identifier.scopus | 2-s2.0-85208473168 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 383 | |
dc.identifier.uri | https://doi.org/10.1080/15569527.2024.2423257 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/17201 | |
dc.identifier.volume | 43 | |
dc.identifier.wos | WOS:001349936400001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation.ispartof | Cutaneous and Ocular Toxicology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WOS_20250406 | |
dc.subject | inflammation | |
dc.subject | acne vulgaris | |
dc.subject | HDL | |
dc.subject | inflammatory markers | |
dc.title | Impact of oral isotretinoin on the inflammatory markers: can lymphocyte/HDL-C and platelet/HDL-C ratios be new indicators of inflammation in acne vulgaris patients? | |
dc.type | Article |